Cargando…

Readministration of Nivolumab after Persistent Immune-related Colitis in a Patient with Recurrent Melanoma

Nivolumab shows promising efficacy against metastatic melanoma. However, immune-related adverse events are of great concern. We herein report a case of persistent colitis that developed during nivolumab monotherapy and nivolumab readministration. An 82-year-old Japanese woman with recurrent melanoma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fujii, Yosuke, Nishikawa, Yoshitaka, Nomura, Motoo, Miyamoto, Shin'ich, Uneno, Yu, Horimatsu, Takahiro, Muto, Manabu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2017
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5938514/ https://www.ncbi.nlm.nih.gov/pubmed/29269640 http://dx.doi.org/10.2169/internalmedicine.8910-17

Ejemplares similares

Association of Chemoradiotherapy With Thoracic Vertebral Fractures in Patients With Esophageal Cancer
por: Fujii, Kota, et al.
Publicado: (2020)

Timing of the infusion of nivolumab for patients with recurrent or metastatic squamous cell carcinoma of the esophagus influences its efficacy
por: Nomura, Motoo, et al.
Publicado: (2023)

Nutritional and clinical outcomes of chemoradiotherapy for clinical T1N0M0 esophageal carcinoma
por: Sakanaka, Katsuyuki, et al.
Publicado: (2019)

Long-term outcome of definitive radiotherapy for cervical esophageal squamous cell carcinoma
por: Sakanaka, Katsuyuki, et al.
Publicado: (2018)

Ipilimumab and Nivolumab-Induced Colitis in a Patient With Recurrent Metastatic Melanoma
por: Moein, Hamid-Reza, et al.
Publicado: (2021)

Readministration of Cancer Drugs in a Patient with Chemorefractory Metastatic Colorectal Cancer
por: Kawagoe, Tetsuro, et al.
Publicado: (2020)

Readministration of Pembrolizumab after Treatment of Tuberculosis Activated by Initial Pembrolizumab Therapy
por: Murakami, Shuji, et al.
Publicado: (2020)

Association of Short-Chain Fatty Acids in the Gut Microbiome With Clinical Response to Treatment With Nivolumab or Pembrolizumab in Patients With Solid Cancer Tumors
por: Nomura, Motoo, et al.
Publicado: (2020)

Tissue Damage in the Canine Normal Esophagus by Photoactivation with Talaporfin Sodium (Laserphyrin): A Preclinical Study
por: Horimatsu, Takahiro, et al.
Publicado: (2012)

Recurrent Drug-induced Liver Injury Caused by the Incidental Readministration of a Kampo Formula Containing Scutellariae Radix
por: Shimada, Yutaka, et al.
Publicado: (2018)

Clinical benefit of readministration of gefitinib for initial gefitinib-responders with non-small cell lung cancer
por: Yokouchi, Hiroshi, et al.
Publicado: (2007)

Readministration of gefitinib in a responder after treatment discontinuation due to gefinitib-related interstitial lung disease: a case report
por: Takamochi, Kazuya, et al.
Publicado: (2007)

Nivolumab and immune‐mediated colitis
por: Walker, Heather, et al.
Publicado: (2019)

A case of long-term survival treated with three metastasectomies and two subsequent adjuvant nivolumab therapies for recurrent malignant melanoma of the esophagus
por: Hanada, Keita, et al.
Publicado: (2022)

Nivolumab in the treatment of malignant melanoma: review of the literature
por: Mashima, Emi, et al.
Publicado: (2015)

Nivolumab-related Sclerosing Cholangitis in Gastric Cancer
por: Motoo, Yoshiharu
Publicado: (2019)

Successful management of hyperammonemia with hemodialysis on day 2 during 5-fluorouracil treatment in a patient with gastric cancer: a case report with 5-fluorouracil metabolite analyses
por: Ozaki, Yoshinao, et al.
Publicado: (2020)

Correction to: Successful management of hyperammonemia with hemodialysis on day 2 during 5‑fluorouracil treatment in a patient with gastric cancer: a case report with 5‑fluorouracil metabolite analyses
por: Ozaki, Yoshinao, et al.
Publicado: (2020)

Efficacy and safety of nivolumab in Japanese patients with first recurrence of glioblastoma: an open-label, non-comparative study
por: Aoki, Tomokazu, et al.
Publicado: (2021)

Repeated talaporfin sodium photodynamic therapy for esophageal cancer: safety and efficacy
por: Tamaoki, Masashi, et al.
Publicado: (2021)

Preclinical Validation of Talaporfin Sodium-Mediated Photodynamic Therapy for Esophageal Squamous Cell Carcinoma
por: Ohashi, Shinya, et al.
Publicado: (2014)

Femoral placement of a totally implantable venous access port with spontaneous catheter fracture: case report
por: Kondo, Tomohiro, et al.
Publicado: (2020)

Decision making for anti-VEGF inhibitor continuation: dip stick? or urine protein/creatinine ratio? (VERSiON UP study)
por: Nakamura, Michio, et al.
Publicado: (2022)

Serotonin syndrome induced by the readministration of escitalopram after a short-term interruption in an elderly woman with depression: a case report
por: Sato, Yasushi, et al.
Publicado: (2015)

Safety of Same-Eye Subretinal Sequential Readministration of AAV2-hRPE65v2 in Non-human Primates
por: Weed, Lindsey, et al.
Publicado: (2019)

Determinants of Attitude Toward End-of-Life Care Among Junior Physicians: Findings from a Nationwide Survey in Japan
por: Watanabe, Yukiko, et al.
Publicado: (2023)

Primary malignant melanoma of the esophagus successfully treated with nivolumab: a case report
por: Ito, Shingo, et al.
Publicado: (2021)

Neoadjuvant relatlimab and nivolumab in resectable melanoma
por: Amaria, Rodabe N., et al.
Publicado: (2022)

Remission of ulcerative colitis flare-up induced by nivolumab
por: Iwamoto, Maho, et al.
Publicado: (2020)

Development and validation of a set of six adaptable prognosis prediction (SAP) models based on time-series real-world big data analysis for patients with cancer receiving chemotherapy: A multicenter case crossover study
por: Uneno, Yu, et al.
Publicado: (2017)

Nonsurgical Management Following Local Resection for Early Rectal Cancer in Patients with High-risk Factors: A Single-institute Experience
por: Nishizaki, Daisuke, et al.
Publicado: (2020)

Colorectal Advanced Neoplasms Occur through Dual Carcinogenesis Pathways in Individuals with Coexisting Serrated Polyps
por: Yamada, Atsushi, et al.
Publicado: (2014)

Risks and benefits of reinduction ipilimumab/nivolumab in melanoma patients previously treated with ipilimumab/nivolumab
por: Chapman, Paul B, et al.
Publicado: (2021)

Readministration of EGFR Tyrosine Kinase Inhibitor in Non-small Cell Lung Cancer Patients after Initial Failure, What Affects its Efficacy?
por: Zhao, Ze-Rui, et al.
Publicado: (2014)

Readministration of high-dose adeno-associated virus gene therapy vectors enabled by ImmTOR nanoparticles combined with B cell-targeted agents
por: Ilyinskii, Petr O, et al.
Publicado: (2023)

Clinical utility of nivolumab in the treatment of advanced melanoma
por: Asmar, Ramsey, et al.
Publicado: (2016)

Nivolumab plus ipilimumab in the treatment of advanced melanoma
por: Tsai, Katy K., et al.
Publicado: (2015)

Bicytopenia in Primary Lung Melanoma Treated with Nivolumab
por: Takahashi, Ayumu, et al.
Publicado: (2018)

The Latest Option: Nivolumab and Relatlimab in Advanced Melanoma
por: Albrecht, Lea Jessica, et al.
Publicado: (2023)

Magnifying image-enhanced endoscopy for collagenous colitis
por: Kobayashi, Masaaki, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_gd6rc6mearsn1f60297ialqmog